| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b05fc9e3f0dedd7bfed9cad572de2f9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-30762
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-38 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-30756 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L23-02 |
| filingDate |
2020-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4a63c9d77b1c162f5da3a1b6e1fc342
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d69166de9a50c428ae44fd9450cb5ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e497085a57114e55c881a75454fbbdd |
| publicationDate |
2022-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2020290074-A1 |
| titleOfInvention |
Diagnosis and treatment |
| abstract |
The present invention provides relatively non-invasive treatments generally involving injection of a treatment composition to a subject's target site which exhibits a defined degradation state (e.g. typically "partially- degraded target sites'') and / or symptoms corresponding with such a degradation state. Such target sites, which are suitably specific regions of a human or animal body (e.g. an intervertebral disc or a component part thereof, such a nucleus pulposus), typically degrade to the defined degradation state as a consequence of biological degeneration at the target site, in particular cellular and/or extracellular degradation, and administration thereto of treatment compositions of the invention can facilitate physical and / or biochemical restoration of such target sites. |
| priorityDate |
2019-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |